Disease & Therapy Review is meant to be an accurate and efficient executive synopsis of the indications that IPD users look up most frequently. Each report includes epidemiology from the IPD (Incidence and Prevalence Database), treatment data and charts, market data and drug cost when available. The reports are collaboration between our epidemiological specialists and senior market research analysts who each have over 15 years of experience.
Note: Subscriptions include full access to all DTR reports as well as access to the senior analyst who wrote any of the reports for further questions or comments.
